XCell® ATF System: Breaking Productivity Barriers In Upstream Bioprocessing

The XCell^® ATF System is an innovative solution designed to address the growing need for efficient and cost-effective biotherapeutic manufacturing. This advanced system utilizes Alternating Tangential Flow (ATF) technology to enable continuous bioprocessing through perfusion cell culture. This process allows for longer run times and higher viable cell densities, resulting in increased productivity and reduced costs.

The XCell ATF System offers a range of benefits, including:

Economic Benefits: Lower cost of goods, reduced capital expenses, and faster time to market.

Productivity Benefits: 10X higher viable cell density, 20X increased yield, linear scalability, and continuous bioprocessing.

Sustainability Benefits: Reduced energy use, waste, bioreactor size, and facility footprint.

The system is highly adaptable and scalable, making it suitable for various applications, from process development to commercial production.

To learn more about the XCell ATF System and its potential to revolutionize your bioprocessing workflow, access the full content here.